382 related articles for article (PubMed ID: 25747841)
1. What strategy should France implement for H2020?
Dhainaut JF; Diebolt V; Pouletty-Lefèbvre B; ; Baker A; Bassompierre F; Borel T; Braunstein D; Demotes J; François B; Huet S; Micallef J; Misse C; Molon A; Rascol O; Ravoire S; Schwartz B; Donne N; Donne N; Fusaï G; Pouletty P; Vicaut E
Therapie; 2015; 70(1):95-109. PubMed ID: 25747841
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the Hungarian participation in the 6th European Union Framework Programme for Research, Technological Development and Demonstration in the thematic priority area of the life sciences].
Pörzse G; Temesi A
Orv Hetil; 2007 Jul; 148(29):1361-71. PubMed ID: 17631471
[TBL] [Abstract][Full Text] [Related]
3. Public-private partnership models in France and in Europe.
Demotes-Mainard J; Canet E; Segard L
Therapie; 2006; 61(4):325-34, 313-23. PubMed ID: 17124948
[TBL] [Abstract][Full Text] [Related]
4. A window of opportunity.
Schiermeier Q
Nature; 2002 Sep; 419(6903):108-9. PubMed ID: 12226634
[No Abstract] [Full Text] [Related]
5. France. Will French science swallow Zerhouni's strong medicine?
Enserink M
Science; 2008 Nov; 322(5906):1312. PubMed ID: 19039109
[No Abstract] [Full Text] [Related]
6. Research funding. Windfall for French biomedical agency.
Balter M
Science; 2000 Oct; 290(5491):423. PubMed ID: 11183750
[TBL] [Abstract][Full Text] [Related]
7. [Organisation of clinical research in France: the new missions of inter-regional delegations for clinical research].
Jaillon P
Bull Acad Natl Med; 2008 May; 192(5):929-37; discussion 937-9. PubMed ID: 19238783
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease public-private partnerships: A landscape of the global nonprofit community.
Snyder HM; Bain LJ; Egge R; Carrillo MC
Alzheimers Dement; 2013 Jul; 9(4):466-71. PubMed ID: 23809367
[No Abstract] [Full Text] [Related]
9. Why French politics and science don't mix.
Nat Mater; 2004 May; 3(5):275. PubMed ID: 15122212
[No Abstract] [Full Text] [Related]
10. [The development of European Union common research and development policy and programs with special regard to life sciences].
Pörzse G
Orv Hetil; 2009 Aug; 150(32):1509-22. PubMed ID: 19632918
[TBL] [Abstract][Full Text] [Related]
11. [A proposal for reforming psychologists' training in France and in the European Union].
Bouchard JP
Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
[TBL] [Abstract][Full Text] [Related]
12. Perspectives for food research and European collaboration in the European Research Area and the new Framework Programme.
Breslin L
Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4 Suppl):16-9. PubMed ID: 11894746
[TBL] [Abstract][Full Text] [Related]
13. An analysis of subject areas and country participation for all health-related projects in the EU's FP5 and FP6 programmes.
Galsworthy MJ; Irwin R; Charlesworth K; Ernst K; Hristovski D; Wismar M; McKee M
Eur J Public Health; 2014 Jun; 24(3):514-20. PubMed ID: 23804079
[TBL] [Abstract][Full Text] [Related]
14. Science in Europe. The new framework for EU research and innovation.
Horvat M
Science; 2011 Nov; 334(6059):1066-8. PubMed ID: 22116869
[No Abstract] [Full Text] [Related]
15. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
16. [French biomedical competitiveness clusters: opportunities for public-private partnerships].
Vasmant D
Bull Acad Natl Med; 2009 Dec; 193(9):2035-43; discussion 2044. PubMed ID: 20666016
[TBL] [Abstract][Full Text] [Related]
17. Scientific funding. Is €80 billion on the horizon for European research?
Reardon S
Science; 2011 Dec; 334(6061):1331-3. PubMed ID: 22158789
[No Abstract] [Full Text] [Related]
18. Biomedical and health research: an analysis of country participation and research fields in the EU's Horizon 2020.
Gallo F; Seniori Costantini A; Puglisi MT; Barton N
Eur J Epidemiol; 2021 Dec; 36(12):1209-1217. PubMed ID: 33205246
[TBL] [Abstract][Full Text] [Related]
19. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
[TBL] [Abstract][Full Text] [Related]
20. [Establishing ophthalmology in the research framework programs of the European Union].
Scholl HP; Wheeler-Schilling TH; Zrenner E; Holz FG
Ophthalmologe; 2006 Feb; 103(2):91-9. PubMed ID: 16437232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
